administration. Her headache resolved in 3 days, and there was improvement in left hemiparesis, and she was transferred to a rehabilitation facility.
Eltrombopag is a thrombopoietin-receptor agonist used as an effective treatment for ITP [1, 2] as well as hepatitis C-associated thrombocytopenia. It is a nonpeptide ligand, binding the thrombopoietin receptor on megakaryocytes and platelets thereby enhancing the megakaryocyte production and platelet maturation. However, adverse effects of the agent include thrombotic episodes due to the release of platelet materials into the circulation. [3] The patient in discussion had no evidence of thrombosis before the administration of the drug. She developed extensive thrombosis following administration of the drug for 4 days. The prevalence of thrombotic episodes with eltrombopag in a randomized controlled trial was higher compared to the placebo group. Neurological deficits with arterial occlusions have also been reported with eltrombopag in the past. [4] However, recently, there are also reports of paradoxical thrombosis in ITP that reveal prothrombotic tendencies in patients with ITP itself, which may also have contributed to the present condition.
The clinical scenario is challenging, especially in the background of severe ITP and low platelet counts. There is a possibility that one may suspect a bleed and order a CT brain to rule that out, missing an early underlying cerebral venous thrombosis. Here, the initial CT scan was normal with no typical features of cerebral sinus thrombosis. However, subsequent clinical deterioration led to MR brain and MR venogram. The diagnosis is important as the decision to anticoagulate is vital. The challenge after the diagnosis is the need for anticoagulation to be instituted in a brain with venous hemorrhagic infarct and low platelet count. The possibility of endovascular treatment should also considered, especially in patients with rapidly deteriorating neurological status. There are prior case reports of successful anticoagulation after thrombosis with eltrombopag. [5] The knowledge of thrombotic complications of this drug would help to detect early complications and initiate necessary management.
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This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. P M D i s a n X -l i n k e d r e c e s s i ve h y p o m ye l i n a t i n g leukodystrophy, characterized by early-onset pendular nystagmus, global developmental delay, and central hypotonia. It is caused by mutations of the PLP1 gene. [1] The spectrum of PLP1-related disorders include the severe connatal PMD, intermediate classical PMD, which is less severe, and the milder phenotype of spastic paraplegia type 2 (SPG2). [2] Whereas the severe forms arise due to missense mutations, deletions and null mutations account for the milder variants such as SPG2. However, the most common mutations are duplications that lead to the classical intermediate form of PMD, as is the current case. Triplication mutations, as described in the current case, are extremely rare. The PLP1 gene encodes the PLP1 and its smaller, spliced form DM20. PLP1/DM20 is the major constituent of oligodendrocytes that forms myelin in the central nervous system and in addition, plays a pivotal role in stabilizing and sustaining the myelin sheath. Moreover, the PLP1/DM20 expression is not solely restricted to the oligodendrocytes. It is, as well, expressed in Schwann cells and neurons of the corticospinal tracts and the brainstem. The expression of this gene across multiple sites in the central nervous system is responsible for the wide spectrum of phenotypic expression of PLP1-related disorders. [3] Leukodystrophies presenting in infancy can be either h y p o m ye l i n a t i n g o r d y s m ye l i n a t i n g . [2] P M D i s a hypomyelinating leukoencephalopathy and close c l i n i c o -r a d i o l o g i c a l d i f f e r e n t i a l s a r e Pe l i z a e u sMerzbacher-like disorder (PMLD) and Salla disease. Characteristic clinical features and radiological presence or absence of basal ganglia, cerebellum, and brainstem involvement helps in differentiating hypomyelinating disorders. This helps in choosing the right geneticdiagnostic test. [3] PMLD is characterized by cerebellar atrophy, whereas Salla disease has characteristic N-acetylaspartate (NAA) peak on magnetic resonance (MR) spectroscopy. [2, 4] The genetic defects in PMLD affect the gap junction alpha-12 (GJA12) and sexdetermining region Y (SRY)-box 10 (SOX10) gene that are responsible for the formation of oligodendrocytes in very early stages. [5] In Salla disease, the underlying pathogenic defect is in a lysosomal transporter protein for sialic acid. Dysmyelinating leukodystrophies such as Cockayne disease, metachromatic leukodystrophy, Krabbe disease, and Canavan disease can also present in infancy but characteristic clinical and radiological features differentiate these disorders from PMD. [2] Recognition of these characteristic clinico-radiological patterns is imperative for appropriate genetic counselling and prognostication, as these disorders have a clinically rapid downhill course.
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There are no conflicts of interest. Clinical picture in our case suggested a high cervical myelopathy. Presence of "main en succulente" pointed to a possible intramedullary lesion as this phenomenon has been described exclusively with intramedullary lesions such as syringomyelia. However, neuroimaging revealed a central disc protrusion at C4-C5 level with cord compression and myelomalacic changes at the same level, with no evidence of any central cord lesion in the spinal segments corresponding to the swollen left hand. In the literature that we reviewed, there was no mention about "main en succulente" with high cervical compressive myelopathy.
Sir, A 50-year-old man presented to us with history of burning pain of his entire left upper limb for the past 10 years. About 7 years, after the onset of symptoms, he noticed similar burning pain in the right lower extremity. He also developed difficulty in walking with a tendency to trip over and fall. On examination, his left hand was soft, smooth, swollen, and cold with shiny skin ("main en succulente") [ Figure 1a -c].
His right hand appeared normal. There was spasticity of both lower limbs. In the left upper limb, there was marked weakness of all small muscles with Grade IV power of left triceps and finger extensors. There was no wasting of the small muscles of left hand. Rest of the muscles was normal in the left upper limb. The power in the other limbs was also normal. Examination of deep tendon reflexes showed brisk triceps with normal biceps and supinator jerks. Lower limb reflexes were brisk with bilateral extensor plantars. Abdominal reflex was not elicitable. On sensory examination, he had impaired pain and temperature perception over both upper limbs below mid forearm as well as over the entire 
